Scottsdale, AZ (October 21, 2014) … The social and economic costs of PTSD (Post Traumatic Stress Disorder) are staggering, with 22 veterans committing suicide per day, or one every 65 minutes. Veterans now account for 20% of all suicides in the U.S, with the youngest veterans, those 24 and under, taking their lives at four times the rate of other veteran age groups. The government has spent more than $2 billion on treatment to date, yet the tragedies continue to escalate.
“We are honored to offer hope and help for those suffering from PTSD (Post Traumatic Stress Disorder), as it is treatable,” says Josette Sullins, founder and CEO of dēhp® therapeutic. “This innovative dēhp® therapeutic tool is a licensed therapy that resolves hidden memories activating PTSD symptoms and consequently transforms lives. It is also an effective and efficient tool licensed therapists can offer their clients who suffer from trauma, addiction and abuse. We have countless success stories about vets who have recovered and we are anxious to offer this treatment to as many people as possible.”
An acronym for developed expression of human potential (pronounced: deep), dēhp® is a transformative process focused on stimulating the innate intelligence of the human body. Designed to help individuals process traumatic experiences, the dēhp® technique has proven anecdotally to be a highly effective tool in treating individuals suffering from PTSD.
Sullins is driven to amp the research up from anecdotal to clinical, and thanks to generous financial support, her dream is becoming a reality in November as she launches an ongoing and unprecedented pilot study on PSTD among Veterans.
Sullins and her team are currently seeking both partners and participants to be a part of this four-phase, fully-funded dēhp® therapeutic pilot study, which will document the benefits and efficacy of the dēhp® technique on individuals with PTSD.
Participants will receive dēhp® therapeutic sessions at no cost (normal fee is $600), followed by 24 hours of treatment by a licensed therapist participating in the study. To be eligible, participants must be current or retired military personnel with a diagnosis of PTSD and be available November 7-9 and for 6 additional treatments scheduled in the following two weeks. They must also be willing to complete a one-page questionnaire at the end of each session to track their progress.
Qualifications for Funded Participating Sponsors: Non-profit organizations employing therapists working with PTSD patients, preferably military veterans, but not exclusively. The study will use the Clinician Administered PTSD Scale (CAPS) to measure each subject’s response to the licensed dēhp® therapeutic technique. The CAPS method of assessment is the highest standard of measurement used by mental health professionals to evaluate individuals with PTSD. The data from this pilot study will be published and used as evidence to fund additional grants. All participating partners are eligible to use the licensed dēhp® technique in their facility as well as the results from this study; will be able to select therapists for the research pilot; and can elect to offer the study to their clients who wish to participate as subjects.